What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Immune system
- Disease
Her primary areas of investigation include Immunology, Tuberculosis, Mycobacterium tuberculosis, Antigen and Latent tuberculosis.
Her Immunology research includes elements of Internal medicine, Disease and Virology.
The Tuberculosis study combines topics in areas such as Public health and Intensive care medicine.
Her study in Mycobacterium tuberculosis is interdisciplinary in nature, drawing from both Cord blood, Antigen-presenting cell, Predictive value of tests, Interleukin 21 and Effector.
Her Antigen research includes themes of Interferon, Interferon gamma and Active tuberculosis.
The Microbiology study which covers Autophagy that intersects with Physiology.
Her most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Towards tuberculosis elimination: an action framework for low-incidence countries (438 citations)
- Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. (424 citations)
What are the main themes of her work throughout her whole career to date?
Delia Goletti spends much of her time researching Tuberculosis, Immunology, Mycobacterium tuberculosis, Internal medicine and Antigen.
Her Tuberculosis research incorporates themes from Biomarker and Disease.
The concepts of her Immunology study are interwoven with issues in Tuberculin, Active tb and Virology.
Her Mycobacterium tuberculosis study integrates concerns from other disciplines, such as Autophagy, Sputum and Microbiology.
Delia Goletti interconnects Gastroenterology and QUANTIFERON-TB GOLD in the investigation of issues within Internal medicine.
The study incorporates disciplines such as Whole blood, T cell, Interferon, Interferon gamma and Cytotoxic T cell in addition to Antigen.
She most often published in these fields:
- Tuberculosis (62.50%)
- Immunology (59.93%)
- Mycobacterium tuberculosis (33.09%)
What were the highlights of her more recent work (between 2018-2021)?
- Tuberculosis (62.50%)
- Internal medicine (23.16%)
- Coronavirus disease 2019 (4.41%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Tuberculosis, Internal medicine, Coronavirus disease 2019, Pneumonia and Immunology.
Her research related to Mycobacterium tuberculosis and Latent tuberculosis might be considered part of Tuberculosis.
Her Interferon gamma release assay study in the realm of Latent tuberculosis interacts with subjects such as Bit.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and QuantiFERON.
Delia Goletti has included themes like Coinfection, Baricitinib and 2019-20 coronavirus outbreak in her Coronavirus disease 2019 study.
Her Pneumonia study incorporates themes from Pandemic, Pediatrics, Viral load and Coronavirus.
Between 2018 and 2021, her most popular works were:
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact. (183 citations)
- Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. (88 citations)
- Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. (54 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Cancer
Delia Goletti mainly focuses on Tuberculosis, Internal medicine, Pneumonia, Coronavirus disease 2019 and 2019-20 coronavirus outbreak.
Her research in Tuberculosis intersects with topics in Infection control, Disease, Coinfection, Prospective cohort study and Triage.
In her study, Immunology is inextricably linked to Tuberculosis reactivation, which falls within the broad field of Disease.
Her Immunology research focuses on Tumor necrosis factor alpha in particular.
Her Pneumonia research integrates issues from Pandemic and Viral load.
Delia Goletti interconnects Mortality rate, Adverse effect, Retrospective cohort study and Baricitinib in the investigation of issues within Coronavirus disease 2019.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
